Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

FDA floats new clinical trial reforms; Takeda punts Denali brain drug

 April 6, 2026

BioPharma Dive

In its budget request, the agency proposed a way to speed up early drug testing and help smaller biotech firms.

Policy / PricingRead full story

Post navigation

Neurocrine to acquire Prader-Will drug in $2.9B Soleno buyout →
← Amgen scores with new thyroid eye disease formulation

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com